C16H12F5N3O2S
Neat
405.34
Enflicoxib; 251442-94-1; VM9PYQ1MQG; E-6087; 1-(4-Aminosulfonylphenyl)-5-(2, 4-difluorophenyl)-4, 5-dihydro-3-trifluoromethyl-1H-pyrazole; 4-(3-(2, 4-Difluorophenyl)-5-(trifluoromethyl)-3, 4-dihydropyrazol-2-yl)benzenesulfonamide; Benzenesulfonamide, 4-(5-(2, 4-difluorophenyl)-4, 5-dihydro-3-(trifluoromethyl)-1H-pyrazol-1-yl)-; 4-[3-(2, 4-difluorophenyl)-5-(trifluoromethyl)-3, 4-dihydropyrazol-2-yl]benzenesulfonamide; RefChem:136829; E-6087, (A+-)-; Enflicoxib [INN]; UNII-VM9PYQ1MQG; E-6087, (+/-)-; 1-(4-aminosulphonylphenyl)-5-(2, 4-difluorophenyl)-4 and 5-dihydro-3-trifluoromethyl-1H-pyrazole; SCHEMBL26427; orb1700676; CHEMBL5315060; AKOS040748300; DA-73108; HY-19384
4-[3-(2, 4-difluorophenyl)-5-(trifluoromethyl)-3 and 4-dihydropyrazol-2-yl]benzenesulfonamide
InChI=1S/C16H12F5N3O2S/c17-9-1-6-12(13(18)7-9)14-8-15(16(19,20)21)23-24(14)10-2-4-11(5-3-10)27(22,25)26/h1-7,14H,8H2,(H2,22,25,26)